Replies to post #427327 on Anavex Life Sciences Corp (AVXL)

[scorman1]

the big bump today for a competitor was for it's data release. Filing an NDA and it's approval are a long way off with the snails pace this outfit seems to execute or rather NOT execute in any timely fashion.
So, in answer to your qs, if our Rett trial results are stellar and unequivacable, IMHO I could expect at SP jump to $20 on the news. To me it would be IGN and worthy of a sig bump.
,